BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16389747)

  • 1. [Innate immunity, receptors for exogenous and endogenous danger patterns in immunopathogenesis of atherosclerosis--part 1: identification of danger signals by innate immunity].
    Krejsek J; Kunes P; Andrýs C; Holická M; Novosad J; Kudlová M; Kolácková M
    Cas Lek Cesk; 2005; 144(12):785-9. PubMed ID: 16389747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Innate immunity, receptors for exogenous and endogenous danger patterns in immunopathogenesis of atherosclerosis--part II: TLR receptors, significance of genetic polymorphism of danger signals receptors].
    Krejsek J; Kunes P; Andrýs C; Holická M; Novosad J; Kudlová M; Kolácková M
    Cas Lek Cesk; 2005; 144(12):790-4. PubMed ID: 16389748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune signals in atherosclerosis.
    Lundberg AM; Hansson GK
    Clin Immunol; 2010 Jan; 134(1):5-24. PubMed ID: 19740706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis.
    Doherty TM; Fisher EA; Arditi M
    Trends Immunol; 2006 May; 27(5):222-7. PubMed ID: 16580258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation.
    Lundberg AM; Yan ZQ
    Curr Opin Lipidol; 2011 Oct; 22(5):343-9. PubMed ID: 21881501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toll-like receptors].
    Essakalli M; Atouf O; Bennani N; Benseffaj N; Ouadghiri S; Brick C
    Pathol Biol (Paris); 2009 Jul; 57(5):430-8. PubMed ID: 18513891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors and innate immunity.
    Kumar H; Kawai T; Akira S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T; Akira S
    Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
    Frantz S; Ertl G; Bauersachs J
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):444-54. PubMed ID: 17653117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrosequencing of toll-like receptor polymorphisms of functional relevance.
    Ahmad-Nejad P
    Methods Mol Biol; 2009; 496():73-87. PubMed ID: 18839106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of innate immunity.
    Hoebe K; Jiang Z; Tabeta K; Du X; Georgel P; Crozat K; Beutler B
    Adv Immunol; 2006; 91():175-226. PubMed ID: 16938541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.
    Carmody RJ; Chen YH
    Cell Mol Immunol; 2007 Feb; 4(1):31-41. PubMed ID: 17349209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity, macrophage activation, and atherosclerosis.
    Yan ZQ; Hansson GK
    Immunol Rev; 2007 Oct; 219():187-203. PubMed ID: 17850490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging.
    Salminen A; Huuskonen J; Ojala J; Kauppinen A; Kaarniranta K; Suuronen T
    Ageing Res Rev; 2008 Apr; 7(2):83-105. PubMed ID: 17964225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases.
    Schaefer L
    Curr Opin Pharmacol; 2010 Apr; 10(2):185-90. PubMed ID: 20045380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRAK-4--a shared NF-kappaB activator in innate and acquired immunity.
    Suzuki N; Saito T
    Trends Immunol; 2006 Dec; 27(12):566-72. PubMed ID: 17046325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The innate signaling of dangers and the dangers of innate signaling.
    Sansonetti PJ
    Nat Immunol; 2006 Dec; 7(12):1237-42. PubMed ID: 17110939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern recognition receptors and control of adaptive immunity.
    Palm NW; Medzhitov R
    Immunol Rev; 2009 Jan; 227(1):221-33. PubMed ID: 19120487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune sensing and activation of cell surface Toll-like receptors.
    Tapping RI
    Semin Immunol; 2009 Aug; 21(4):175-84. PubMed ID: 19493685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.